About Caidya

Caidya works as a global, multi-therapeutic clinical research organization (CRO) that focuses on advancing healthcare and accelerating the development of new therapies. The organization offers comprehensive clinical trial services, including regulatory strategy and submissions, clinical operations, biometrics, and quality management, as well as post-approval surveillance. It caters to the healthcare industry, leveraging its in-depth therapeutic and operational expertise to conduct studies efficiently and with standards. Caidya was formerly known as dMed Biopharmaceutical. It was founded in 2021 and is based in Raleigh, North Carolina.